Measure of public health prepardeness in respect of APIs / intermediate / KSMs which are closely monitor the production and availability of APIs and their formulations to prevent black marketing and hoarding.

Drug controller cum licensing authority, director of health services, Chandigarh are monitoring for availability of APIs and drugs in context of outbreak of COVID-19 in China. NPPA (National Pharmaceutical pricing authority) chairman had written a letter to Drug Controller, Chandigarh and all the other State's/ UTs Chief Secretaries for taking measures on price control due to COVID-19 outbreak in the country.

The Government has made amendments in the export policy and restricted export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from 13 APIs for safety purpose due to COVID-19 outbreak in India. A notification issued by Directorate General of Foreign Trade, Commerce and Industry says that the restrictions will come into immediate effect and until further orders.

e-Pharmacies strictly do not accept orders for habit forming medicines, narcotics, or any other sensitive medicines. Additionally, given the importance of the e-Pharmacy sector globally, several large investors have recently reached out to the e-Pharmacy players, expressing concern about the general investment and regulatory climate in India